Teva Pharmaceutical Industries Ltd. ADR (TEVA)
NYSE
Closed
Oct 9, 2026
Day's Range
40.1252 wk Range
18.83Overview - TEVA - Teva Pharmaceutical Industries Ltd. ADR
Key Statistics
Valuation
Enterprise Value
58.91B
P/E (Trailing)
‪65.31‬
P/E (Forward)
‪12.87‬
PEG Ratio
‪-0.22‬
Price / Sales (TTM)
‪2.63‬
Price / Book
‪5.89‬
EV / EBITDA
‪13.80‬
Profitability
Gross Margin
‪51.97%‬
Profit Margin
‪4.07%‬
Operating Margin
‪4.03%‬
Return on Assets
‪5.12%‬
Return on Equity
‪9.69%‬
Ownership
Shares Outstanding
1.16B
Float
1.08B
Short % of Shares Outstanding
‪2.71%‬
Held by Insiders
‪0.52%‬
Held by Institutions
‪23.00%‬
Price stats
Beta
‪0.79‬
50-Day Avg
‪36.10‬
200-Day Avg
‪33.44‬
Dividends
Payout Ratio
‪0.00%‬
Frequency
Quarterly
Analyst Consensus
6 analysts
Average price target
‪$ 41.40‬Market Cap - TEVA - Teva Pharmaceutical Industries Ltd. ADR
Peers - TEVA - Teva Pharmaceutical Industries Ltd. ADR
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on NYSE.
Profile Summary - TEVA - Teva Pharmaceutical Industries Ltd. ADR
About
Teva Pharmaceutical Industries Ltd. ADR is a global pharmaceutical company focused on the development, production, and sale of medicines. Teva Pharmaceutical Industries Ltd. offers a broad portfolio that includes generic medicines, specialty branded treatments, over-the-counter products, active pharmaceutical…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
